- Discharge criteria should be validated in patients who undergo ambulatory gynecologic surgery
-
Kim K, Kim BJ, Kim MH, Choi SC, Ryu SY
- KMID: 2288580
- J Gynecol Oncol.
- 2011 Jun;22(2):140-141.
- doi: 10.3802/jgo.2011.22.2.140
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic single-site surgery: from research to clinical practice?
-
Escobar PF
- KMID: 2288568
- J Gynecol Oncol.
- 2011 Jun;22(2):65-66.
- doi: 10.3802/jgo.2011.22.2.65
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Quality of life in gynecologic cancer survivors compared to healthy check-up women
-
Wilailak S, Lertkhachonsuk Aa, Lohacharoenvanich N, Luengsukcharoen SC, Jirajaras , Likitanasombat P, Sirilerttrakul S
- KMID: 2288574
- J Gynecol Oncol.
- 2011 Jun;22(2):103-109.
- doi: 10.3802/jgo.2011.22.2.103
OBJECTIVE: The primary objective of this study was to compare quality of life of disease-free patients after therapy for gynecologic malignancies at follow-up in comparison with healthy check-up patients. Our... -
- CITED
-
- Close
- SHARE
-
- Close
- Single-port access laparoscopic staging operation for a borderline ovarian tumor
-
Yoon A, Kim TJ, Lee WS, Kim BG, Bae DS
- KMID: 2288577
- J Gynecol Oncol.
- 2011 Jun;22(2):127-130.
- doi: 10.3802/jgo.2011.22.2.127
Minimally invasive surgery is widely used in benign gynecologic diseases and may be used in malignancies. We performed a single-port access laparoscopy staging - bilateral salpingo-oophorectomy, laparoscopy-assisted vaginal hysterectomy, bilateral... -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic single-port transumbilical total hysterectomy: a pilot study
-
Nam EJ, Kim SW, Lee M, Yim GW, Paek JH, Lee SH, Kim S, Kim JH, Kim JW, Kim YT
- KMID: 2288576
- J Gynecol Oncol.
- 2011 Jun;22(2):120-126.
- doi: 10.3802/jgo.2011.22.2.120
OBJECTIVE: To evaluate the feasibility of robotic single-port transumbilical total hysterectomy using a home-made surgical glove port system. METHODS: We retrospectively reviewed the medical records of patients who underwent robotic single-port... -
- CITED
-
- Close
- SHARE
-
- Close
- Major surgeries performed for gestational trophoblastic neoplasms in a teaching hospital in Tehran, Iran
-
Ghaemmaghami F, Ashrafgangooei T, Gillani MM, Mosavi A, Behtash N
- KMID: 2288573
- J Gynecol Oncol.
- 2011 Jun;22(2):97-102.
- doi: 10.3802/jgo.2011.22.2.97
OBJECTIVE: This study aim was to evaluate indications and outcomes of surgical interventions performed in patients with gestational trophoblastic neoplasm. METHODS: During January 1995 to December 2005, 110 patients with a... -
- CITED
-
- Close
- SHARE
-
- Close
- Pure choriocarcinoma of the ovary: a case report
-
Lv L, Yang K, Wu H, Lou J, Peng Z
- KMID: 2288579
- J Gynecol Oncol.
- 2011 Jun;22(2):135-139.
- doi: 10.3802/jgo.2011.22.2.135
Pure ovarian choriocarcinomas are extremely rare and aggressive tumors which are gestational or non-gestational in origin. Due to the rarity of the tumor, there is a lack of information on... -
- CITED
-
- Close
- SHARE
-
- Close
- Cervical cancer in the screening era: who fell victim in spite of successful screening programs?
-
Pettersson BF, Hellman K, Vaziri R, Andersson , Hellstrom
- KMID: 2288570
- J Gynecol Oncol.
- 2011 Jun;22(2):76-82.
- doi: 10.3802/jgo.2011.22.2.76
OBJECTIVE: To compare profiles of a prescreening and screening cohort of women with cervical cancer regarding histopathology and clinical variables in order to identify those remaining at risk despite successful... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance
-
Yilmaz E, Koyuncuoglu M, Gorken IB, Okyay E, Saatli B, Ulukus EC, Saygili U
- KMID: 2288572
- J Gynecol Oncol.
- 2011 Jun;22(2):89-96.
- doi: 10.3802/jgo.2011.22.2.89
OBJECTIVE: To determine matrix metalloproteinase-2 and survivin expressions in endometrial cancers, their relation to clinical and histologic parameters and to investigate any difference in the expression of these markers between... -
- CITED
-
- Close
- SHARE
-
- Close
- Sonographic diagnosis and Endo-SPONGE assisted vacuum therapy of anastomotic leakage following posterior pelvic exenteration for ovarian cancer without using a protective stoma
-
Einenkel J, Holler B, Hoffmeister A
- KMID: 2288578
- J Gynecol Oncol.
- 2011 Jun;22(2):131-134.
- doi: 10.3802/jgo.2011.22.2.131
Anastomotic leakage is a very significant complication after posterior pelvic exenteration and a major cause of postoperative morbidity and mortality. We present a patient who underwent an optimal debulking surgery... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer
-
Cerne JZ, Pohar-Perme M, Novakovic , Frkovic-Grazio S, Stegel V, Gersak K
- KMID: 2288575
- J Gynecol Oncol.
- 2011 Jun;22(2):110-119.
- doi: 10.3802/jgo.2011.22.2.110
OBJECTIVE: Estrogen plays a key role in breast cancer development and functionally relevant genetic variants within the estrogen metabolic pathway are prime candidates for a possible association with breast cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
-
Song T, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS
- KMID: 2288571
- J Gynecol Oncol.
- 2011 Jun;22(2):83-88.
- doi: 10.3802/jgo.2011.22.2.83
OBJECTIVE: It is clear that uterine carcinosarcomas and uterine papillary serous carcinomas (UPSC) have an adverse impact on outcome, but whether carcinosarcomas are worse than UPSC is unclear. The purpose... -
- CITED
-
- Close
- SHARE
-
- Close
- Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
-
Kim SC, Song YS, Kim YT, Kim YT, Ryu KS, Gunapalaiah B, Bi D, Bock HL, Park JS
- KMID: 2288569
- J Gynecol Oncol.
- 2011 Jun;22(2):67-75.
- doi: 10.3802/jgo.2011.22.2.67
OBJECTIVE: The study assessed the immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Korean women aged 15-25 years. METHODS: Phase IIIB, double-blind, randomised (2:1), multi-centre trial... -
- CITED
-
- Close
- SHARE
-
- Close
